Jpmorgan Chase & CO Milestone Scientific Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Milestone Scientific Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 346 shares of MLSS stock, worth $318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
346
Previous 356
2.81%
Holding current value
$318
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MLSS
# of Institutions
34Shares Held
4.45MCall Options Held
13.3KPut Options Held
500-
Vanguard Group Inc Valley Forge, PA2.18MShares$2.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA550KShares$505,7750.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX356KShares$327,0600.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2252KShares$231,6860.15% of portfolio
-
State Street Corp Boston, MA140KShares$128,6940.0% of portfolio
About MILESTONE SCIENTIFIC INC.
- Ticker MLSS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 68,920,896
- Market Cap $63.4M
- Description
- Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that...